254 related articles for article (PubMed ID: 17545842)
1. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
Stevens W; Stevens G; Kolbe J; Cox B
J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
[TBL] [Abstract][Full Text] [Related]
2. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
Stevens W; Stevens G; Kolbe J; Cox B
Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
[TBL] [Abstract][Full Text] [Related]
3. Ethnic differences in the management of lung cancer in New Zealand.
Stevens W; Stevens G; Kolbe J; Cox B
J Thorac Oncol; 2008 Mar; 3(3):237-44. PubMed ID: 18317065
[TBL] [Abstract][Full Text] [Related]
4. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
5. Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.
Dickhoff C; Dahele M; de Langen AJ; Paul MA; Smit EF; Senan S; Hartemink KJ; Damhuis RA
J Thorac Oncol; 2016 Apr; 11(4):566-72. PubMed ID: 26773741
[TBL] [Abstract][Full Text] [Related]
6. Gaps in optimal care for lung cancer.
Vinod SK; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L; Armstrong B
J Thorac Oncol; 2008 Aug; 3(8):871-9. PubMed ID: 18670305
[TBL] [Abstract][Full Text] [Related]
7. [Current treatment concepts of lung cancer].
Kaiser F; Engelhardt M; Rawluk J; Mertelsmann R; Passlick B; Wäsch R
Dtsch Med Wochenschr; 2011 Sep; 136(38):1901-6. PubMed ID: 21915805
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognosis of advanced stage non-small-cell lung cancer].
Chermiti Ben Abdallah F; Ben Ali G; Sadok Boudaya M; Mlika M; Chtourou A; Taktak S; Ben Kheder A
Rev Mal Respir; 2014 Mar; 31(3):214-20. PubMed ID: 24680112
[TBL] [Abstract][Full Text] [Related]
9. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
10. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
Yang YJ; Park JC; Kim HK; Kang JH; Park SY
Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
[TBL] [Abstract][Full Text] [Related]
11. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
13. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
14. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
[TBL] [Abstract][Full Text] [Related]
15. Auditing a new lung cancer service.
Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
[TBL] [Abstract][Full Text] [Related]
16. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC
J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
[TBL] [Abstract][Full Text] [Related]
17. Treatment of small cell lung carcinoma in the elderly.
Dajczman E; Fu LY; Small D; Wolkove N; Kreisman H
Cancer; 1996 May; 77(10):2032-8. PubMed ID: 8640666
[TBL] [Abstract][Full Text] [Related]
18. Why do some lung cancer patients receive no anticancer treatment?
Vinod SK; Sidhom MA; Gabriel GS; Lee MT; Delaney GP
J Thorac Oncol; 2010 Jul; 5(7):1025-32. PubMed ID: 20453689
[TBL] [Abstract][Full Text] [Related]
19. Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000.
Ellis PM; Delaney G; Della-Fiorentina S; Moylan E
Australas Radiol; 2004 Sep; 48(3):364-70. PubMed ID: 15344988
[TBL] [Abstract][Full Text] [Related]
20. Predictors of surgery and consult with an oncologist for adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada.
Winget M; Stanger J; Gao Z; Butts C
J Thorac Oncol; 2009 May; 4(5):629-34. PubMed ID: 19276835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
